临床数据分析解决方案市场 - 解决方案、应用、最终用途、全球预测

由于医疗保健产业内合作的增加，临床数据分析解决方案市场规模从 2024 年到 2032 年的复合年增长率预计将达到 12.8%。解决方案提供者和技术公司正在整合这些解决方案，以简化患者护理并改善治疗结果。利益相关者正在合作，利用预测分析和人工智慧的力量来个性化患者护理并优化医疗服务。

随着医疗保健系统的不断发展，这些合作伙伴关係透过数据驱动的见解和协作努力帮助改善患者的治疗结果。例如，2024 年 4 月，IQVIA 和 Salesforce 宣布扩大全球策略合作伙伴关係，将 IQVIA 临床资料分析解决方案与 Salesforce 生命科学云端整合。此次合作透过先进的分析和统一平台帮助增强了客户在全球生命科学产业的参与。

临床资料分析解决方案产业分为解决方案、应用程式、最终用途和区域。

透过解决方案，由于采用高级分析来有效解释患者资料，服务领域的市场规模将在 2024 年至 2032 年间录得可观的增长率。这些服务使医疗保健提供者能够即时做出数据驱动的决策，以增强患者护理和治疗策略。临床资料分析还与人工智慧和机器学习等新兴技术整合，以进一步优化医疗保健服务，同时确保患者和提供者高效且有效的医疗保健管理。

在应用方面，预计2024年至2032年精准健康领域的临床资料分析解决方案市场将出现显着的复合年增长率。临床资料分析解决方案彻底改变了精准健康，这些解决方案利用先进的分析技术以前所未有的准确性分析个人健康资料。这些解决方案使医疗保健提供者能够根据从广泛资料集中获得的个人化见解来客製化治疗和介入措施。最近，一些精准健康计画也在推进，以整合基因资料、穿戴式技术和即时监测，以进一步完善预测模型和治疗策略。

由于远距医疗和远距患者监测技术的广泛采用，到 2032 年，亚太地区临床资料分析解决方案产业规模将创下显着的复合年增长率。这些创新使医疗保健提供者能够利用先进的分析技术即时监控患者健康资料，从而远端提供护理服务。高效率的医疗服务。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

• 产业生态系统分析
• 产业影响力
  • 成长动力
    • 越来越多地采用电子健康记录 (EHR)
    • 对即时资料洞察的需求不断增长，以改善患者的治疗效果
    • 开发新疗法的临床研究不断增长
    • 对降低临床研究失败风险的需求不断增长
  • 产业陷阱与挑战
    • 与临床资料相关的安全和隐私问题
    • 与资料品质和整合相关的问题
• 成长潜力分析
• 监管环境
• 波特的分析
• PESTEL分析

第 4 章：竞争格局

• 介绍
• 公司市占率分析
• 公司矩阵分析
• 竞争定位矩阵
• 战略仪表板

第 5 章：市场估计与预测：按解决方案，2021 - 2032 年

• 主要趋势
• 平台
  • 基于云端
  • 本地部署
• 服务
  • 咨询服务
  • 整合和实施服务
  • 支援和维护服务

第 6 章：市场估计与预测：按应用分类，2021 - 2032

• 主要趋势
• 临床决策支持
• 精准健康
• 品质改进和临床基准测试
• 监理报告和合规性
• 其他应用

第 7 章：市场估计与预测：按最终用途，2021 - 2032 年

• 主要趋势
• 製药和生物技术公司
• 供应商
• 付款人
• 其他最终用户

第 8 章：市场估计与预测：按地区，2021 - 2032

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 荷兰
  • 欧洲其他地区
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
  • 亚太地区其他地区
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 拉丁美洲其他地区
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋
  • 中东和非洲其他地区

第 9 章：公司简介

• Allscripts Healthcare Solutions, Inc.
• CareCloud Corporation
• Cerner Corporation
• Dassault Systemes
• eClinical Solutions LLC

96 灵感公司

• IQVIA 公司
• 医学分析公司
• 医疗资讯科技公司
• 奥普图姆公司
• 甲骨文公司
• Qsi管理有限公司
• SAS 研究所
• 特鲁文健康分析公司
• 维里斯克分析公司

Clinical Data Analytics Solutions Market size is set to record 12.8% CAGR from 2024 to 2032 due to the rise in collaborations within the healthcare sector. Solution providers and technology firms are integrating these solutions to streamline patient care and improve treatment outcomes. Stakeholders are collaborating to harness the power of predictive analytics and AI to personalize patient care and optimize healthcare delivery.

With the evolving healthcare systems, these partnerships are helping in improving patient outcomes through data-driven insights and collaborative efforts. For instance, in April 2024, IQVIA and Salesforce announced an expanded global strategic partnership to integrate IQVIAs clinical data analytics solutions with Salesforce Life Sciences Cloud. This collaboration helped enhance customer engagement in the global life sciences industry through advanced analytics and a unified platform.

The clinical data analytics solutions industry is segmented into solution, application, end-use, and region.

By solution, the market size from the services segment will record a decent growth rate between 2024 and 2032, due to the adoption of advanced analytics to interpret patient data effectively. These services are enabling healthcare providers to make data-driven decisions in real time for enhancing patient care and treatment strategies. Clinical data analytics are also integrated with emerging technologies like AI and machine learning to further optimize healthcare delivery while ensuring efficient and effective healthcare management for patients and providers.

In terms of application, the clinical data analytics solutions market from the precision health segment is anticipated to witness significant CAGR from 2024-2032. Precision health is revolutionized by clinical data analytics solutions which are utilizing advanced analytics to analyze individual health data with unprecedented accuracy. These solutions are enabling healthcare providers to tailor treatments and interventions based on personalized insights derived from extensive data sets. Lately, several precision health initiatives are also advancing for integrating gnomic data, wearable technology, and real-time monitoring to further refine predictive models and treatment strategies.

Asia Pacific clinical data analytics solutions industry size will record significant CAGR through 2032 due to the widespread adoption of telehealth and remote patient monitoring technologies. These innovations are enabling healthcare providers to deliver care remotely by leveraging advanced analytics to monitor patient health data in real time.With the evolving healthcare delivery, telehealth and remote monitoring is facilitating more accessible and efficient healthcare services across diverse populations in the region.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing adoption of electronic health records (EHRs)
    • 3.2.1.2 Rising demand for real-time data insights to enhance patient outcomes
    • 3.2.1.3 Growth in clinical studies for developing new therapeutics
    • 3.2.1.4 Growing demand for mitigating the risk of failures in clinical studies
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Security and privacy concerns related to clinical data
    • 3.2.2.2 Issues related to data quality and integration
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Porter's analysis
• 3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Solution, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Platform
  • 5.2.1 Cloud-based
  • 5.2.2 On-premise
• 5.3 Services
  • 5.3.1 Consulting services
  • 5.3.2 Integration and implementation services
  • 5.3.3 Support and maintenance services

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Clinical decision support
• 6.3 Precision health
• 6.4 Quality improvement and clinical bench marking
• 6.5 Regulatory reporting and compliance
• 6.6 Other applications

Chapter 7 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Pharmaceutical and biotechnology companies
• 7.3 Providers
• 7.4 Payers
• 7.5 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
  • 8.3.7 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
  • 8.4.6 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Rest of Latin America
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE
  • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

• 9.1 Allscripts Healthcare Solutions, Inc.
• 9.2 CareCloud Corporation
• 9.3 Cerner Corporation
• 9.4 Dassault Systemes
• 9.5 eClinical Solutions LLC

96 Inspirata Inc.

• 9.7 IQVIA Inc.
• 9.8 Medeanalytics, Inc.
• 9.9 Medical Information Technology Inc.
• 9.10 Optum, Inc.
• 9.11 Oracle Corporation
• 9.12 Qsi Management LLC
• 9.13 SAS Institute, Inc.
• 9.14 Truven Health Analytics, Inc.
• 9.15 Verisk Analytics, Inc